Medicare Advantage Enrollment by Beneficiaries With End-Stage Renal Disease

JAMA Network March 14, 2023
Kevin H. Nguyen, PhD; Eunhae G. Oh, MPP; David J. Meyers, PhD; Daeho Kim, PhD; Rajnish Mehrotra, MD, MS; Amal N. Trivedi, MD, MPH

Key Points

Question How did enrollment in Medicare Advantage among beneficiaries with end-stage renal disease (ESRD) change after the implementation of the 21st Century Cures Act (which allowed enrollment de novo in Medicare Advantage for patients with ESRD), and what were the characteristics of Medicare beneficiaries with ESRD who switched from traditional Medicare to Medicare Advantage?

Findings In this cross-sectional study of 575 797 Medicare beneficiaries with ESRD, the proportion enrolled in Medicare Advantage increased by 51%. Increases were largest among Black, Hispanic, and dual-eligible (Medicare and Medicaid) beneficiaries.

Meaning Among people with ESRD, increases in Medicare Advantage enrollment in the first year after implementation of the 21st Century Cures Act were substantial, particularly among dual-eligible beneficiaries and those from racial...

Today's Sponsors

Today's Sponsor